Skip to content

Clinical trials

Phase 3 Heartburn trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Heartburn Phase: Phase 3 Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20042
20055
20065
20081
20094
20102
20112
20121
20131
20161
20221
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24
Active, not recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Takeda5
Novartis4
AstraZeneca3
Eisai Inc.2
Abbott1
Ahn-Gook Pharmaceuticals Co.,Ltd1
Braintree Laboratories1
Chang Gung Memorial Hospital1
Forest Laboratories1
Janssen Pharmaceutica N.V., Belgium1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Heartburn27
Gastroesophageal Reflux17
Dyspepsia4
Nausea2
Vomiting2
Abdominal Pain1
Anorexia1
Digestive System Diseases1
Esophagitis1
Gastroparesis1

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.